BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 28070123)

  • 21. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study.
    Martínez-Pinteño A; Mezquida G; Bioque M; López-Ilundain JM; Andreu-Bernabeu Á; Zorrilla I; Mané A; Rodríguez-Jiménez R; Corripio I; Sarró S; Ibáñez Á; Usall J; Rivero O; Gassó P; Leza JC; Cuesta MJ; Parellada M; González-Pinto A; Berrocoso E; Mas S; Bernardo M;
    Eur Neuropsychopharmacol; 2022 Apr; 57():105-117. PubMed ID: 35219096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased serum neurotrophin levels related to alcohol use disorder in a young population sample.
    Lhullier AC; Moreira FP; da Silva RA; Marques MB; Bittencourt G; Pinheiro RT; Souza LD; Portela LV; Lara DR; Jansen K; Wiener CD; Oses JP
    Alcohol Clin Exp Res; 2015 Jan; 39(1):30-3. PubMed ID: 25623403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cannabis use on blood levels of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF): A systematic review and meta-analysis.
    Shafiee A; Rafiei MA; Jafarabady K; Eskandari A; Abhari FS; Sattari MA; Amini MJ; Bakhtiyari M
    Brain Behav; 2024 Jan; 14(1):e3340. PubMed ID: 38376038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-dependent time course of cerebral brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 in APP23 transgenic mice.
    Schulte-Herbrüggen O; Eckart S; Deicke U; Kühl A; Otten U; Danker-Hopfe H; Abramowski D; Staufenbiel M; Hellweg R
    J Neurosci Res; 2008 Sep; 86(12):2774-83. PubMed ID: 18438945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis.
    Bora E
    Psychol Med; 2019 Sep; 49(12):1971-1979. PubMed ID: 31284882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of Fibroblast Growth Factor 10 in the Peripheral Blood of Patients with Schizophrenia.
    Yu Y; Xie GJ; Hu Y; Li XS; Chen GY; Zheng GE; Chen X; Cheng Y
    J Mol Neurosci; 2019 Sep; 69(1):69-74. PubMed ID: 31256336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats.
    Sartorius A; Hellweg R; Litzke J; Vogt M; Dormann C; Vollmayr B; Danker-Hopfe H; Gass P
    Pharmacopsychiatry; 2009 Nov; 42(6):270-6. PubMed ID: 19924587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor.
    Angelucci F; Ricci V; Pomponi M; Conte G; Mathé AA; Attilio Tonali P; Bria P
    J Psychopharmacol; 2007 Nov; 21(8):820-5. PubMed ID: 17715210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral levels of BDNF and NGF in primary headaches.
    Blandini F; Rinaldi L; Tassorelli C; Sances G; Motta M; Samuele A; Fancellu R; Nappi G; Leon A
    Cephalalgia; 2006 Feb; 26(2):136-42. PubMed ID: 16426267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
    Bilgiç A; Toker A; Işık Ü; Kılınç İ
    Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring Serum Levels of Brain Derived Neurotrophic Factor and Nerve Growth Factor Across Glaucoma Stages.
    Oddone F; Roberti G; Micera A; Busanello A; Bonini S; Quaranta L; Agnifili L; Manni G
    PLoS One; 2017; 12(1):e0168565. PubMed ID: 28068360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of IL-1Ra are associated with schizophrenia.
    Zhou Y; Peng W; Wang J; Zhou W; Zhou Y; Ying B
    Psychiatry Clin Neurosci; 2019 Mar; 73(3):109-115. PubMed ID: 30375100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Efficacy of Non-Pharmacological Interventions on Brain-Derived Neurotrophic Factor in Schizophrenia: A Systematic Review and Meta-Analysis.
    Sanada K; Zorrilla I; Iwata Y; Bermúdez-Ampudia C; Graff-Guerrero A; Martínez-Cengotitabengoa M; González-Pinto A
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis.
    Carvalho AF; Köhler CA; McIntyre RS; Knöchel C; Brunoni AR; Thase ME; Quevedo J; Fernandes BS; Berk M
    Psychoneuroendocrinology; 2015 Dec; 62():18-26. PubMed ID: 26210676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain-derived neurotrophic factor and its serum levels in schizophrenic patients.
    Koeva YA; Sivkov ST; Akabaliev VH; Ivanova RY; Deneva TI; Grozlekova LS; Georgieva V
    Folia Med (Plovdiv); 2014; 56(1):20-3. PubMed ID: 24812918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain-derived neurotrophic factor as a biomarker for obsessive-compulsive disorder: A meta-analysis.
    Hao LS; Du Y; Chen L; Jiao YG; Cheng Y
    J Psychiatr Res; 2022 Jul; 151():676-682. PubMed ID: 35667336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum neurotrophins--a study on the time course and influencing factors in a large old age sample.
    Ziegenhorn AA; Schulte-Herbrüggen O; Danker-Hopfe H; Malbranc M; Hartung HD; Anders D; Lang UE; Steinhagen-Thiessen E; Schaub RT; Hellweg R
    Neurobiol Aging; 2007 Sep; 28(9):1436-45. PubMed ID: 16879899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral brain-derived neurotrophic factor in autism spectrum disorder: a systematic review and meta-analysis.
    Zheng Z; Zhang L; Zhu T; Huang J; Qu Y; Mu D
    Sci Rep; 2016 Aug; 6():31241. PubMed ID: 27506602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis.
    Raap U; Werfel T; Goltz C; Deneka N; Langer K; Bruder M; Kapp A; Schmid-Ott G; Wedi B
    Allergy; 2006 Dec; 61(12):1416-8. PubMed ID: 17073871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of dexmedetomidine and placebo on the plasma concentrations of NGF, BDNF, GDNF, and epinephrine during severe alcohol withdrawal.
    Reynolds PM; Mueller SW; MacLaren R
    Alcohol; 2015 Feb; 49(1):15-9. PubMed ID: 25638740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.